OXEIA BIOPHARMACEUTICALS INC has a total of 20 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2015. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are WNTRESEARCH AB, ONE HEALTH VENTURES LTD and METASTAT INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Australia | 3 | |
#4 | Canada | 3 | |
#5 | EPO (European Patent Office) | 3 | |
#6 | Israel | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Munshi Amit Dilip | 18 |
#2 | Shah Kartik Kiran | 18 |
#3 | Batra Reema | 5 |
Publication | Filing date | Title |
---|---|---|
WO2017075535A1 | Methods of treating neurodegenerative conditions | |
AU2016229848A1 | Methods of treating cognitive impairments or dysfunction | |
AU2015305647A1 | Methods of treating mild brain injury | |
EP3197482A1 | Methods of treating traumatic brain injury |